Biotechnology stocks as represented by the IBB and XBI etfs have shown plenty of relative strength of late. With earnings season upon us these stocks could get a further boost, and even more so through a multi-quarter view if m&a activity resumes.
Want my tips and tricks to the markets? Subscribe and learn more about trading and investing, get an upper hand on the markets and on the path to a steadier trading and investing process. By subscribing you can expect to get anywhere from 2-4 new videos each week with clear, actionable, and relevant market commentary directly in your inbox. Not to mention you’ll be the first to know when we have upcoming Live Training Sessions. Enter your name and email and welcome to The Steady Trader family.
Trading contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing one’s financial security or lifestyle. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. Read our Full Disclaimers HERE.
By giving your contact info you agree to receive future emails from The Steady Trader including educational and promotional content. By providing your mobile phone number and clicking on the above “Subscribe” button, you agree to receive automated promotional messages from us via SMS. By opting into our SMS Program, you agree to our Terms and Conditions and Privacy Policy.
